Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | G469R |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | BRAF G469R is a hotspot mutation within the protein kinase domain of the Braf protein (UniProt.org). G469R demonstrates intermediate BRAF kinase activity (PMID: 28783719), results in constitutive ERK activation in cell culture (PMID: 24920063), and in one of two cell lines leads to increased cell proliferation and cell viability compared to wild-type Braf (PMID: 29533785), and therefore, is predicted to lead to a gain of Braf protein function. |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF act mut BRAF G469R BRAF mutant BRAF G469X BRAF G469R |
Transcript | NM_004333.6 |
gDNA | chr7:g.140781603C>T |
cDNA | c.1405G>A |
Protein | p.G469R |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001378468.1 | chr7:g.140781603C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
XM_005250045 | chr7:g.140781603C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140781603C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
NM_001378470.1 | chr7:g.140778001C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
NM_004333 | chr7:g.140781603C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140781603C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140781603C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140781603C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140781603C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140781603C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
NM_001378467.1 | chr7:g.140781612C>T | c.1405G>A | p.G469R | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03843775 | Phase Ib/II | Binimetinib + Encorafenib | A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers | Completed | USA | 0 |